Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, uniQure (QURE) has a market cap of $0.52 billion USD. According to our data, uniQure is ranked No.5925 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.52 B |
-44.70%
|
| Dec 31, 2024 | $0.94 B |
160.86%
|
| Dec 29, 2023 | $0.36 B |
-70.14%
|
| Dec 30, 2022 | $1.21 B |
9.31%
|
| Dec 31, 2021 | $1.11 B |
-42.60%
|
| Dec 31, 2020 | $1.93 B |
-49.58%
|
| Dec 31, 2019 | $3.83 B |
148.65%
|
| Dec 31, 2018 | $1.54 B |
47.12%
|
| Dec 29, 2017 | $1.05 B |
249.82%
|
| Dec 30, 2016 | $0.30 B |
-66.14%
|
| Dec 31, 2015 | $0.88 B |
11.68%
|
| Dec 31, 2014 | $0.79 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
| Market Cap | = | QURE Stock Price | * | QURE Shares Outstanding |
| = | $9.65 | * | 54.08 M | |
| = | $0.52 B |